Patents by Inventor Kimberly Allen

Kimberly Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS
    Publication number: 20210307320
    Abstract: Compositions that contain microencapsulated plant beneficial gram negative bacteria are provided, methods of using the compositions to treat plants or plant parts, and treated plants or plant parts are provided.
    Type: Application
    Filed: May 29, 2019
    Publication date: October 7, 2021
    Inventors: Kimberly ALLEN, Desmond JIMENEZ
  • Microbial inoculant formulations
    Patent number: 10757946
    Abstract: Compositions comprising dried formulations of viable Methylobacterium as well as methods for making and using the formulations are provided. In particular the compositions provide for Methylobacterium formulations with improved viability, shelf-life, and plant or seed treatment characteristics.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: September 1, 2020
    Assignee: NEWLEAF SYMBIOTIC, INC.
    Inventors: Kimberly Allen, Gregg Bogosian
  • Microbial Inoculant Formulations
    Publication number: 20160073641
    Abstract: Compositions comprising dried formulations of viable Methylobacterium as well as methods for making and using the formulations are provided. In particular the compositions provide for Methylobacterium formulations with improved viability, shelf-life, and plant or seed treatment characteristics.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 17, 2016
    Inventors: Kimberly Allen, Gregg Bogosian
  • Recombinant DNA Vectors for Expression of Human Prolactin Antagonists
    Publication number: 20110129873
    Abstract: Embodiments of the present invention relate generally to methods and compositions for producing human prolactin antagonists. Embodiments of the present invention also relate to various methods for improved production of human prolactin antagonists by microorganisms. These microorganisms, including Escherichia coli, can be transformed to enable the expression of human prolactin antagonists at high levels using conventional and inexpensive fermentation conditions and inexpensive induction conditions, as described herein.
    Type: Application
    Filed: April 30, 2009
    Publication date: June 2, 2011
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Gregg Bogosian, Patricia Morris, Jennifer Chou, Kimberly Allen, Julia Frantz, Brad Storrs, Jacob Tou
  • Polymorph of a pharmaceutical
    Publication number: 20070015804
    Abstract: A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.
    Type: Application
    Filed: September 21, 2006
    Publication date: January 18, 2007
    Inventors: John Bauer, Azita Saleki-Gerhardt, Bikshandarkoil Narayanan, Sanjay Chemburkar, Ketan Patel, Harry Spiwek, Philip Bauer, Kimberly Allen
  • Polymorph of a pharmaceutical
    Publication number: 20050203152
    Abstract: A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.
    Type: Application
    Filed: May 4, 2005
    Publication date: September 15, 2005
    Inventors: John Bauer, Azita Saleki-Gerhardt, Bikshandarkoil Narayanan, Sanjay Chemburkar, Ketan Patel, Harry Spiwek, Philip Bauer, Kimberly Allen
  • Compositions and methods for genetic analysis of polycystic kidney disease
    Patent number: 6916619
    Abstract: The subject invention relates to methods for detection of mutations in a PKD gene using DHPLC. The invention includes the following aspects: identification of PKD unique sites; design of PKD-specific primers; amplification of PKD-specific products; and analysis of PCR amplified products by DHPLC. The invention further relates to compositions such as identified unique sites and PKD-specific primers, and kits for performing the methods of the invention.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: July 12, 2005
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey George Jones, Aidan Noel Hennigan, John A. Curran, Susan Kimberly Allen, Normand J. Robichaud, Jing Wang, Kerry Ellen Flynn, Jorge A. Garcés, Christopher M. Palatucci
  • Polymorph of a pharmaceutical
    Publication number: 20050009756
    Abstract: A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.
    Type: Application
    Filed: July 29, 2004
    Publication date: January 13, 2005
    Inventors: John Bauer, Azita Saleki-Gerhardt, Bikshandarkoil Narayanan, Sanjay Chemburkar, Ketan Patel, Harry Spiwek, Philip Bauer, Kimberly Allen
  • Compositions and methods for genetic analysis of polycystic kidney disease
    Publication number: 20030152936
    Abstract: The subject invention relates to methods for detection of mutations in a PKD gene using DHPLC. The invention includes the following aspects: identification of PKD unique sites; design of PKD-specific primers; amplification of PKD-specific products; and analysis of PCR amplified products by DHPLC. The invention further relates to compositions such as identified unique sites and PKD-specific primers, and kits for performing the methods of the invention.
    Type: Application
    Filed: February 26, 2002
    Publication date: August 14, 2003
    Applicant: Athena Diagnostics
    Inventors: Jeffrey George Jones, Aidan Noel Hennigan, John A. Curran, Susan Kimberly Allen, Normand J. Robichaud, Jing Wang, Kerry Ellen Flynn, Jorge A. Garces, Christopher M. Palatucci